Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Varicella Zoster Virus Infection | 1 | 2019 | 40 | 0.77 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.65 | Why? |
| Microbiological Techniques | 1 | 2019 | 232 | 0.64 | Why? |
| Sepsis | 3 | 2021 | 3517 | 0.47 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.39 | Why? |
| Workflow | 1 | 2019 | 2373 | 0.38 | Why? |
| Liver Transplantation | 1 | 2020 | 2864 | 0.28 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 3 | 2020 | 1165 | 0.26 | Why? |
| Receptors, Interleukin-1 | 1 | 2020 | 161 | 0.19 | Why? |
| Triage | 1 | 2019 | 7151 | 0.19 | Why? |
| Natural Killer T-Cells | 1 | 2020 | 191 | 0.19 | Why? |
| Acyclovir | 1 | 2019 | 154 | 0.18 | Why? |
| Interferon-gamma Release Tests | 1 | 2020 | 253 | 0.18 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.16 | Why? |
| Latent Tuberculosis | 1 | 2020 | 324 | 0.16 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.15 | Why? |
| Administration, Intravenous | 1 | 2019 | 1115 | 0.14 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.14 | Why? |
| Intestines | 1 | 2020 | 817 | 0.13 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.13 | Why? |
| Opportunistic Infections | 1 | 2019 | 602 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.12 | Why? |
| Waiting Lists | 1 | 2020 | 1388 | 0.11 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.11 | Why? |
| Social Stigma | 1 | 2020 | 1049 | 0.11 | Why? |
| Gene Expression Profiling | 2 | 2021 | 3788 | 0.11 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Endoscopy | 1 | 2020 | 1564 | 0.09 | Why? |
| Tissue and Organ Procurement | 1 | 2020 | 1277 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.08 | Why? |
| Liver | 1 | 2020 | 4007 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Organ Transplantation | 1 | 2020 | 2616 | 0.07 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.06 | Why? |
| Clonal Evolution | 1 | 2021 | 55 | 0.06 | Why? |
| Italy | 6 | 2021 | 38444 | 0.06 | Why? |
| Cell Plasticity | 1 | 2021 | 75 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Humans | 17 | 2021 | 930598 | 0.05 | Why? |
| Immunoglobulin Isotypes | 1 | 2021 | 308 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Hospitals, University | 2 | 2021 | 4173 | 0.05 | Why? |
| Lymphopenia | 2 | 2020 | 2669 | 0.05 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Diffusion of Innovation | 1 | 2021 | 440 | 0.04 | Why? |
| Social Discrimination | 1 | 2020 | 269 | 0.04 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.02 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.02 | Why? |
| Female | 7 | 2021 | 380317 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Communication | 1 | 2020 | 5206 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
Mangioni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(167)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_